Microcap Company, Kabra Drugs Limited Reports Strong Q3FY26 Results and Bold Expansion Moves
Feb 17, 2026
Chennai (Tamil Nadu) [India], February 17: PAT rose 578% compared to last year as Kabra Drugs Limited (BSE: 524322), a fast-emerging microcap company, announced its unaudited financial results for the quarter ended December 31, 2025, on February 13, 2026, alongside a series of strategic initiatives approved earlier on January 1, 2026. Together, these milestones underscore the Company's turnaround momentum, its diversification into high-growth industries, and the strong investor rally that has driven its stock up nearly 200% over the past year.
Read More...
